Turning Point Brands Targets 10% Modern Oral Nicotine Share by 2030

Turning Point Brands (NYSE: TPB) is betting that its modern oral nicotine portfolio will be its primary growth driver, targeting a double-digit share of the category by the end of the decade. Management reiterated this growth plan at the IDEAS Conference, suggesting a strategic push into higher-growth product demand. The update is supportive but not accompanied by near-term financial figures, so likely limited immediate stock impact.